Baxion
ScreeningTagsAlerts

Nasus Pharma Ltd.

NSRX

Financials

20-FAnnual report (foreign)03/25/26

Disclosures

6-KForeign issuer report10/08/266-KForeign issuer report09/18/266-KForeign issuer report09/14/266-KForeign issuer report09/04/266-KForeign issuer report08/19/26

Prospectuses and Registrations

S-8Registration of securities for employees10/19/26424B5Prospectus supplement09/18/26F-3Shelf registration (foreign)09/01/26POS AMPost-effective amendment08/19/26S-8Registration of securities for employees05/26/26

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership09/23/26Form 4Insider transaction09/21/26SC 13G/ABeneficial ownership (amended)08/14/26Form 3Initial insider ownership07/31/26Form 4Insider transaction07/29/26

Other

EFFECTRequest for effectiveness09/11/26EFFECTRequest for effectiveness08/20/26EFFECTRequest for effectiveness03/31/26EFFECTRequest for effectiveness03/13/26CORRESPCorrespondence with the SEC03/11/26

Latest Filings

S-8Registration of securities for employees10/19/266-KForeign issuer report10/08/266-KForeign issuer report09/18/26424B5Prospectus supplement09/18/266-KForeign issuer report09/14/26

Ownership

Form 3Initial insider ownership09/23/26Form 4Insider transaction09/21/26SC 13G/ABeneficial ownership (amended)08/14/26Form 3Initial insider ownership07/31/26Form 4Insider transaction07/29/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact